Scientific Council on Chronic Thromboembolic Pulmonary Hypertension
COUNCIL LEADERSHIP OPERATING BOARDCOUNCIL CHAIR: NOT A COUNCIL MEMBER?
Council membership is open to all ISHLT members. Joining is easy. Simply login to the ISHLT Members Only Website
where you can update your membership profile and join any of the 12 Scientific Councils.
in La Jolla AB of the Manchester Grand Hyatt Hotel, San Diego CA, USA, during the ISHLT 37th Annual Meeting and Scientific Sessions
After much deliberation, the ISHLT Board of Directors has approved the establishment of a separate CTEPH (chronic thromboembolic pulmonary hypertension) Council within the Society. The idea to create a separate Council was born out of complimentary goals from CTEPH expert members and ISHLT leadership to have a reliable international platform to discuss and engage multinational CTEPH experts in important domain projects, and for the ISHLT to engage the world-wide community and increase its membership. Among several other relevant points, some domain experts in the field of CTEPH who know the community best (especially from the surgical and interventional side of the discipline, who do not presently engage in the Society), have felt a strong need to have an independent platform separate from the PH council through which they can congregate and spend adequate time evaluating new therapies and establishing best practices. The ISHLT hopes to provide this international “home” for the CTEPH community. All interested ISHLT members are invite to join the CTEPH Council. The first Chair of the new CTEPH Council, Dr. William Auger from the University of California San Diego, has been appointed by the Board for a 2-year term. Forthcoming officers will be elected by the membership of the Council.
UCSD Medical Center
San Diego, California, USAbauger@ucsd.eduDr. Auger is currently a Professor of Clinical Medicine at the University of California, San Diego School of Medicine, and the director of UCSD's Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Program. Having devoted 30 years to the management of CTEPH patients, his academic interests focus on the evaluation and treatment of pulmonary hypertension, particularly chronic thromboembolic disease and other large vessel pulmonary vascular disorders.
Dr. Auger accepted his faculty appointment at UC San Diego in 1989 after he completed a three-year pulmonary and critical care fellowship at the same university. Prior to this, he undertook a critical care fellowship at Ellis Hospital, an affiliate of Albany Medical Center in New York. He completed his Internal Medicine residency at Strong Memorial Hospital in Rochester, New York after earning his medical degree from the University of Rochester School of Medicine.
Dr. Auger is a member of the American Thoracic Society, the International CTEPH Association, the Pulmonary Vascular Research Institute, the Pulmonary Hypertension Association, the International Society for Heart and Lung Transplantation, the International Society on Thrombosis and Hemostasis, and a fellowship of the American College of Chest Physicians.